Dr. Khanna gives an Update on Scleroderma to rheumatologists at the NYU Langone Seminar in Advanced Rheumatology on March 16th. View schedule.
Dr. Amber Young, Kate Homer, and Dr. Dinesh Khanna find that a significant proportion of patients have coexisting pulmonary hypertension that occurs early after SSc-ILD diagnosis, "Pulmonary Hypertension Often Occurs Early After SSc-ILD Diagnosis".
Results from clinical trials FaSScinate and FocuSSced are recognized at the Basic and Clinical Immunology for the Busy Clinician symposium, "Tocilizumab Better Than Placebo in Preserving Forced Vital Capacity in Systemic Sclerosis".
Dr. Pei-Suen (Eliza) Tsou, Phillip Campbell, Dr. M. Asif Amin, Patrick Coit, Shaylynn Miller, Dr. David Fox, Dr. Dinesh Khanna, and Dr. Amr Sawalha discover a specific molecule that could be contributing to the progression of scleroderma in patients, "Inhibiting Cancer-Causing Protein Could Prevent Scleroderma Fibrosis".
Dr. Khanna co-authors the updated Pulmonary Hypertension Association Pulmonary Hypertension & Scleroderma Brochure.
Dr. Khanna publishes an updated version of the Scleroderma Foundation Digestive System Involvement in Scleroderma Medical Report.
Dr. Khanna, who led development of a novel, recently endorsed scleroderma outcome measure, discusses current and future clinical trials and treatments, "Systemic Scleroderma Treatments: Where Are We Now?"
Dr. Khanna is an invited speaker at the 55th Annual André Aisenstadt Memorial Clinical Day in Montreal, Canada to honor the achievements of Dr. Murray Baron. View schedule.
Dr. Khanna was an invited guest at the Emirates Society of Rheumatology and American College of Rheumatology meeting in Dubai, UAE. Speakers included (L to R): Dr. Nigrovic, Dr. Khanna, Dr. Petri, Dr. Daikh, Dr. Lakhanpal, Dr. Ritchlin, and Dr. O’Dell.
Dr. Dinesh Khanna and the Scleroderma Program team featured on Michigan Medicine Health Blog, Living with Scleroderma: Personalized Treatment & Support Makes All the Difference.
Dr. Dinesh Khanna to speak at the Scleroderma Foundation’s National Patient Education Conference in July 2018.
Dr. Dinesh Khanna is invited to chair the Monsoon Rheumatology Summit on scleroderma, which is taking place in Cochin, India, July 2018.
Dr. Dinesh Khanna is a guest speaker on ReachMD and discusses managing patients with SS-ILD, Interstitial Lung Disease in Scleroderma: Early Recognition and Emerging Therapeutic Options.
Jody Fisher, Program Manager of the Scleroderma Program, was nominated for an Evan Newport HOPE Award and ended up a HOPE Finalist for Adult Services, out of over 100 nominations.
Sheri Hicks, a patient of the U-M Scleroderma Program talks about her experience with the Scleroderma Program and Program Director, Dr. Dinesh Khanna, in USA Today, "Journey of hope: Autoimmune disease patient raises funds, promotes education". View pictures from the event at right.
View the recent Pulmonary Hypertension & Scleroderma Brochure written and developed by Dr. Khanna for the Pulmonary Hypertension Association.
Dr. Khanna featured in Michigan Medicine Headlines, Service Spotlight: Doc's Commitment to Patient 'Priceless'
Doctors, professors, and professionals from the ASSET study met from around the world at the University of Michigan to discuss the progress of the study, as well as the successes of its collaboration.
Dr. Khanna serves as a member of the Teaching Faculty at the 18th Singapore Society of Rheumatology-Malaysian Society of Rheumatology Workshops in Rheumatology 2017. View the 18th Singapore Society of Rheumatology-Malaysian Society of Rheumatology Workshops in Rheumatology 2017 website to learn more about the event.
The STAR Trial of Habeo Cell Therapy in Patients with Scleroderma announces details and results from its study. This form of cell therapy appears to benefit patients with the diffuse form of the disease, representing a valuable new piece of information for the field. Learn more about the STAR trial and the announcement from Cytori.
The 2017 Scleroderma Foundation National Patient Education Conference was held July 21 to July 23 in Chandler, Arizona.
NIAMS (National Institute of Arthritis and Musculoskeletal and Skin Diseases) hosted a Twitter chat on June 29, with experts from across the nation participating. Read more.
On June 4, 2017, the Scleroderma Foundation Michigan Chapter hosted its annual Stampede Scleroderma event: a 5k at the Detroit Zoo to raise money for scleroderma research, support, and education.
Dr. Khanna and colleagues publish "Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis" in the Journal of Scleroderma and Related Disorders.
The University of Michigan Division of Rheumatology releases the Autumn 2016 edition of its newsletter, RheUMinations. This edition features information on the Scleroderma Program, including the RESCUE study, Dr. Tsou's New Investigator Award, and a number of presentations to be held during the 2016 ACR National Meeting.
Professor Khanna attends the First Scleroderma meeting arranged by the Indian Rheumatology Association in Bangalore, India.
"Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment" article was published by the UM Scleroderma Program and Occupational Therapy Division in the Department of Physical Medicine and Rehabilitation.
UM Scleroderma team leads a pilot study of pirfenidone in scleroderma-associated lung fibrosis. Read more.
The Scleroderma Program hosted its Scleroderma Update event, where patients were able to talk to doctors and coordinators about the latest research. View pictures.
Dr. Khanna is honored in the Spring 2016 edition of Medicine at Michigan.
UM Scleroderma Program publishes pilot study of acupressure in Raynaud’s phenomenon. Read more.
Dr. Khanna publishes "Emerging strategies for treatment of systemic sclerosis."
On Sunday, June 5, 2016, UM Scleroderma Research team members participated in the 2016 Stampede Scleroderma Walk at the Detroit Zoo. As part of the event, a 10K run, 5K run, 1 mile run, and a Zoo walk were all offered to participants. There was a tremendous turnout for the event, and best of all, we missed the rain by minutes!
UM Scleroderma Program Director is the lead author for 2 large clinical trials in scleroderma. Read more. Learn more about the "Effect of Macitentan on the Development of New Ischemic Digital Ulcers in Patients With Systemic Sclerosis".
Dr. Khanna publishes findings of the FaSScinate study in The Lancet. Learn more about the "Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial".
Dr. Tsou receives the Marta Marx Fund for the Eradication of Scleroderma.
Dr. Khanna and the UM Scleroderma Program led the development of the "American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis", which has the potential to revolutionize the conduct of clinical trials in systemic sclerosis. Supplemental material.
Dr. Dinesh Khanna receives the Henry Kunkel Young Investigator Award from the American College of Rheumatology, which is part of the ACR Awards of Distinction, a series of awards given out annually to recognize its members’ contributions to the field of rheumatology. The Henry Kunkel Young Investigator Award is awarded to a young physician scientist, age 45 or younger by October 1 of the year in which they are nominated, who has made outstanding and promising independent contributions to basic or clinical research in the field of rheumatology.
Dr. Khanna speaks on Scleroderma at the Harvard Rheumatology CME Program.
The APLAR 2015 meeting, organized by the American College of Rheumatology, was held in Chennai, India.
The Prospective Registry of Systemic Sclerosis (PRESS) is featured in Scleroderma Voice magazine. The PRESS Registry recently received the Scleroderma Foundation Collaborative Research (SCORE) grant.
Dr. Khanna presents at the 33rd Annual Carl M. Pearson Memorial Symposium.
Meeting of the The Prospective Registry of Systemic Sclerosis (PRESS) at the University of Michigan. The project spans 11 centers, and met to standardize and align research efforts in the various fields at each center.
Medical School honors 70 faculty and staff at Dean’s Awards, research league events.
The University of Michigan Medical School recently celebrated outstanding faculty and staff during a pair of awards ceremonies in the Gilbert S. Omenn Atrium of the A. Alfred Taubman Biomedical Science Research Building.
Dr. Dinesh Khanna was honored with the Dean’s Awards for his service to the school’s tripartite mission. He received this award for being an outstanding educator, investigator, and clinician.
"Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Gastrointestinal Symptom Scales", co-written by Dr. Dinesh Khanna, is published in The American Journal of Gastroenterology.
Dr. Dinesh Khanna featured in the May 2014 IRA e-bulletin.
April 16, 2014
"U-M, MSU Researchers Find 'Off' Switch for Scleroderma". Discovery brings researchers one step closer to unraveling devastating disease.
April 3, 2014
"Flipping the Switch on Scleroderma". Colleagues from Michigan State University and the University of Michigan have identified the core signaling pathway that activates the disease and the chemical compounds that can turn it off.
"Targeting the Myofibroblast Genetic Switch: Inhibitors of MRTF/SRF-regulated Gene Transcription Prevent Fibrosis in a Murine Model of Skin Injury", The Journal of Pharmacology and Experimental Therapeutics.
February 6-8, 2014
Dr. Khanna speaks at the 3rd Systemic Sclerosis World Congress in Rome, Italy. He also served on the Steering Committee.
New scleroderma classification criteria published by ACE/ EULAR. Dr. Khanna participated and played a pivotal role in developing this criteria. Learn more.
Dr Khanna invited to Hamilton, New Zealand to present at their annual rheumatology meeting. Dr. Khanna discussed the latest evidence in the management of pulmonary arterial hypertension and other topics on diagnosis and management of scleroderma.
Dr. Khanna presented the first recommendations for screening and diagnosis of connective tissue disease-associated pulmonary arterial hypertension at the annual EULAR meeting in Madrid, Spain.
- About Us
- Meet the Team
- Patient Care
- UCLA SCTC 2.0 GI Questionnaire
- Friends and Supporters
- Education and Training
- Achievements and News
- Contact Us